Back to BCTXZ

CITADEL ADVISORS LLC → BCTXZ

CITADEL ADVISORS LLC BCTXZ Position History

BriaCell Therapeutics Corp. • Healthcare

Quarters held
18
Latest value
$717K
Q2 2026
Peak value
$1M
First seen
Q2 2023

Dollar value over time

Show data table
PeriodPosition value
Q2 2023$48K
Q2 2023$409K
Q4 2023$111K
Q4 2023$6K
Q4 2023$87K
Q1 2024$68K
Q1 2024$15K
Q1 2024$18K
Q2 2024$912
Q2 2024$7K
Q2 2024$11K
Q3 2024$86K
Q4 2024$78K
Q4 2024$3K
Q3 2025$122K
Q1 2026$1M
Q2 2026$717K
Q2 2026$717K

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q2 2026$717K895.9K——
Q2 2026$717K895.9K——
Q1 2026$1M1.05M——
Q3 2025$122K11.1K——
Q4 2024$3K5.8K——
Q4 2024$78K138.3K——
Q3 2024$86K69.3K——
Q2 2024$11K9.6K——
Q2 2024$7K5.8K——
Q2 2024$912800——
Q1 2024$18K6.4K——
Q1 2024$15K5.4K——
Q1 2024$68K23.7K——
Q4 2023$87K15.0K——
Q4 2023$6K1.1K——
Q4 2023$111K18.9K——
Q2 2023$409K63.6K——
Q2 2023$48K7.5K——

Other funds holding BCTXZ

Other CITADEL ADVISORS LLC positions

ETHA

ISHARES TR

$13.2B
ETHA

ISHARES TR

$13.2B
SPY

SPDR S&P 500 ETF TR

$3B
ETHA

ISHARES TR

$2.7B
SPY

SPDR S&P 500 ETF TR

$2.6B
NVDA

NVIDIA CORPORATION

$2.1B
SPY

SPDR S&P 500 ETF TR

$2.1B
NVDA

NVIDIA CORPORATION

$2.1B